- Filed
- Nov 14, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2023 · Nov 14, 2023 | 57.11M sh |
| Shares Diluted | Q3 2023 · Sep 30, 2023 | 57.11M sh |
| Shares Diluted | Q3 2023 · Sep 30, 2023 | 57.11M sh |
| Shares Diluted | Q3 2023 · Sep 30, 2022 | 57.11M sh |
| Shares Diluted | Q3 2023 · Sep 30, 2022 | 57.11M sh |
| Cash And Equivalents | Q3 2023 · Sep 30, 2023 | $31.09K |
| Cash And Equivalents | Q3 2023 · Dec 31, 2022 | $7.78K |
| Current Liabilities | Q3 2023 · Sep 30, 2023 | $3.47M |
| Current Liabilities | Q3 2023 · Dec 31, 2022 | $3.23M |
| Total Liabilities | Q3 2023 · Sep 30, 2023 | $3.47M |
| Total Liabilities | Q3 2023 · Dec 31, 2022 | $3.23M |
| Current Assets | Q3 2023 · Sep 30, 2023 | $31.09K |
| Current Assets | Q3 2023 · Dec 31, 2022 | $7.78K |
| Total Assets | Q3 2023 · Sep 30, 2023 | $31.09K |
| Total Assets | Q3 2023 · Dec 31, 2022 | $7.78K |
| Operating Cash Flow | Q3 2023 · Sep 30, 2022 | −$718.5K |
| Stockholders Equity | Q3 2023 · Sep 30, 2022 | −$2.84M |
| Stockholders Equity | Q3 2023 · Jun 30, 2022 | −$2.88M |
| Stockholders Equity | Q3 2023 · Mar 31, 2022 | −$2.93M |
| Stockholders Equity | Q3 2023 · Dec 31, 2021 | −$3.01M |
| Eps Diluted | Q3 2023 · Sep 30, 2022 | $0.01 |
| Sga Expense | Q3 2023 · Sep 30, 2022 | $47.3K |
| Sga Expense | Q3 2023 · Sep 30, 2022 | $424.83K |
| Rd Expense | Q3 2023 · Sep 30, 2022 | $0 |
| Net Income | Q3 2023 · Sep 30, 2022 | $20.58K |
| Net Income | Q3 2023 · Sep 30, 2022 | −$704.35K |
| Net Income | Q3 2023 · Jun 30, 2022 | $14.82K |
| Net Income | Q3 2023 · Mar 31, 2022 | −$739.75K |
| Operating Income restated | Q3 2023 · Sep 30, 2022 | $100.43K |
| Operating Income | Q3 2023 · Sep 30, 2022 | −$1.4M |